Impact of COVID-19 primary healthcare service restrictions on patients with chronic obstructive pulmonary disease in Cape Town, South Africa
DOI:
https://doi.org/10.7196/SAMJ.2022.v112i9.16385Keywords:
Covid-19, COPDAbstract
Background. Patients with chronic obstructive pulmonary disease (COPD) typically experience multidimensional symptoms throughout the course of their disease, with burdensome physical symptoms, social isolation, and additional psychological suffering. COVID-19 lockdown resulted in restrictions on chronic care delivery at primary healthcare (PHC) facilities, and it is not known what the care experiences of patients with COPD were during this time.
Objectives. To describe patient experiences of the impact of the lockdown on their needs and their experiences of the primary care received for their COPD.
Methods. The data reported in this paper are from a cohort of 49 patients with COPD receiving primary care, recruited in February and
March 2020, before recruitment was paused for COVID-19 lockdown, for a feasibility stepped-wedge hybrid type II design randomised
controlled trial of integrated person-centred palliative care in primary care for patients with COPD in Cape Town, South Africa. Data are
open-text responses from participants who responded to a single question on a validated measure of primary care consultation empathy (CARE), and describe patient experiences of the impact of the lockdown on the primary care received for their COPD, prior to crossover to trial intervention.
Results. Thirty-two patients with COPD gave between 1 and 9 responses each to the open-ended question between March and December 2020. The average age of the participants was 58.6 years, and 53.1% (n=17) were female. Inductive analysis of the open-text data identified four main themes. Participants described decreased access to chronic care and a desire for more person-centred care in interactions with healthcare professionals. The socioeconomic ramifications of the COVID-19 lockdown added to the burden they experienced.
Conclusion. The COVID-19 lockdown PHC service restrictions caused a disruption to the continuity of care for patients with COPD,
with associated worry, anxiety and disappointment. Medication access was largely supported by the home delivery of chronic medication. We suggest that there are opportunities for providing more sustained support for patients with COPD through referrals to community health workers, and also through telephonic patient follow-up by primary care teams
References
Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health 2015;5(2):020415. https://doi.org/10.7189/jogh.05-020415
AllwoodB,vanZyl-SmitRN.ChronicobstructivepulmonarydiseaseinSouthAfrica:Under-recognised and undertreated. S Afr Med J 2015;105(9):785-785. https://doi.org/10.7196/SAMJnew.8429
Carkeek EC. The burden of chronic respiratory disease in the Western Cape. MPH dissertation. Cape Town: University of Cape Town, 2018. http://hdl.handle.net/11427/29663 (accessed 26 December 2021).
Pearson M, Ayres JG, Sarno M, Massey D, Price D. Diagnosis of airway obstruction in primary care in the UK: The CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997 - 2001. Int J Chron Obstruct Pulmon Dis 2006;1(4):435-443. https://doi.org/10.2147/copd.2006.1.4.435
Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. Can Med Assoc J 2010;182(7):673-678. https://doi. org/10.1503/cmaj.091784
CasasHerreraA,MontesdeOcaM,LopezVarelaMV,etal.COPDunderdiagnosisandmisdiagnosisina high-risk primary care population in four Latin American countries: A key to enhance disease diagnosis: The PUMA study. PLoS ONE 2016;11(4):e0152266. https://doi.org/10.1371/journal.pone.0152266
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2021 report. 2020. https:// goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf (accessed 26 December 2021).
Jithoo A. Respiratory symptoms and chronic obstructive pulmonary disease: Prevalence and risk factors in a predominantly low-income urban area of Cape Town, South Africa. PhD thesis. Cape Town: University of Cape Town, 2006. http://hdl.handle.net/11427/8913 (accessed 26 December 2021).
KokturkN,AbuharbidW,AlbannaAS,etal.Across-sectionalstudyinpatientswithsevereCOPDtoassess the perception of symptom variability (COPVAR) in the Middle East and Africa. Int J Chron Obstruct Pulmon Dis 2019;14:2959-2970. https://doi.org/10.2147/COPD.S215859
SuissaS,Dell’AnielloS,ErnstP.Long-termnaturalhistoryofchronicobstructivepulmonarydisease:Severe exacerbations and mortality. Thorax 2012;67(11):957-963. https://doi.org/10.1136/thoraxjnl-2011-201518 11. Sepúlveda CM, Marlin A, Yoshida T, Ullrich A. Palliative care: The World Health Organization’s perspective. J Pain Symptom Manage 2002;24(2):91-96. https://doi.org/10.1016/s0885-3924(02)00440-2
HigginsonIJ,BauseweinC,ReillyCC,etal.Anintegratedpalliativeandrespiratorycareserviceforpatients with advanced disease and refractory breathlessness: A randomised controlled trial. Lancet Respir Med
;2(12):979-987. https://doi.org/10.1016/S2213-2600(14)70226-7
Cohen J, Beernaert K, van den Block L, et al. Differences in place of death between lung cancer and COPD
patients: A 14-country study using death certificate data. NPJ Prim Care Respir Med 2017;27(1):14. https://
doi.org/10.1038/s41533-017-0017-y
Beernaert K, Cohen J, Deliens L, et al. Referral to palliative care in COPD and other chronic diseases: A population-based study. Respir Med 2013;107(11):1731-1739. https://doi.org/10.1016/j.rmed.2013.06.003
Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31(1):58-69. https://doi.org/10.1016/j.jpainsymman.2005.06.007
Lenferink A, Brusse-Keizer M, van der Valk PD, et al. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017, Issue 8. Art. No. CD011682. https://doi.org/10.1002/14651858.CD011682.pub2
AllwoodB,CalligaroG.Pathogenesisofchronicobstructivepulmonarydisease:AnAfricanperspective.S Afr Med J 2015;105(9):789-792. https://doi.org/10.7196/SAMJnew.8424
South African Government. Regulations and Guidelines – Coronavirus COVID-19. (2020, 2021). https:// www.gov.za/covid-19/resources/regulations-and-guidelines-coronavirus-covid-19 (accessed 29 July 2021). 19. Filby S, van der Zee K, van Walbeek C. The temporary ban on tobacco sales in South Africa: Lessons for endgame strategies. Tob Control 2021 (epub 20 January 2021). https://doi.org/10.1136/tobaccocontrol-2020-056209
Saieva P, Jenkins LS. When people do not ‘Zol’: Reduced emergency centre attendance of patients with chronic obstructive pulmonary disease during coronavirus disease 2019 lockdown with the accompanying tobacco sales ban in South Africa. Afr J Prim Health Care Fam Med 2021;13(1):2750. https://doi. org/10.4102/phcfm.v13i1.2750
Pillay Y, Pienaar S, Barron P, et al. Impact of COVID-19 on routine primary healthcare services in South Africa. S Afr Med J 2021;111(8):714-719. https://doi.org/10.7196/SAMJ.2021.v111i8.15786
SewardN,MurdochJ,HanlonC,etal.Implementationscienceprotocolforaparticipatory,theory-informed implementation research programme in the context of health system strengthening in sub-Saharan Africa (ASSET-ImplementER). BMJ Open 2021;11(7):e048742. https://doi.org/10.1136/bmjopen-2021-048742
Mercer SW, Maxwell M, Heaney D, et al. The Consultation and Relational Empathy (CARE) measure: Development and preliminary validation and reliability of an empathy-based consultation process measure. Fam Pract 2004;21(6):699-705. https://doi.org/10.1093/fampra/cmh621
Cornick R, Picken S, Wattrus C, et al. The Practical Approach to Care Kit (PACK) guide: Developing a clinical decision support tool to simplify, standardise and strengthen primary healthcare delivery. BMJ Glob Health 2018;3(Suppl 5):e000962. https://doi.org/10.1136/bmjgh-2018-000962
HighetG,CrawfordD,MurraySA,BoydK.DevelopmentandevaluationoftheSupportiveandPalliative Care Indicators Tool (SPICT): A mixed-methods study. BMJ Support Palliat Care 2014;4(3):285-290. https://doi.org/10.1136/bmjspcare-2013-000488
Boyd K, Murray SA. Recognising and managing key transitions in end of life care. BMJ 2010;341:c4863.
https://doi.org/10.1136/bmj.c4863
SPICT (Supportive and Palliative Care Indicators Tool). SPICT-SA. https://www.spict.org.uk/the-spict/spict-sa/ (accessed 26 December 2021).
Mercer SW, McConnachie A, Maxwell M, et al. Relevance and practical use of the Consultation and Relational Empathy (CARE) measure in general practice. Fam Pract 2005;22(3):328-334. https://doi.org/10.1093/fampra/cmh730
O’Cathain A, Thomas KJ. ‘Any other comments?’ Open questions on questionnaires – a bane or a bonus to research? BMC Med Res Methodol 2004;4:25. https://doi.org/10.1186/1471-2288-4-25
HarrisPA,TaylorR,ThielkeR,PayneJ,GonzalezN,CondeJG.Researchelectronicdatacapture(REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019;95:103208. https://doi.org/10.1016/j.jbi.2019.103208 32. Kiger ME, Varpio L. Thematic analysis of qualitative data: AMEE Guide No. 131. Med Teach 2020;42(8):846-854. https://doi.org/10.1080/0142159X.2020.1755030
Alsallakh MA, Sivakumaran S, Kennedy S, et al. Impact of COVID-19 lockdown on the incidence and
mortality of acute exacerbations of chronic obstructive pulmonary disease: National interrupted time series
analyses for Scotland and Wales. BMC Med 2021;19(1):124. https://doi.org/10.1186/s12916-021-02000-w 34. GonzalezJ,Moncusi-MoixA,BenitezID,etal.ClinicalconsequencesofCOVID-19lockdowninpatients with COPD: Results of a pre-post study in Spain. Chest 2021;160(1):135-138.. https://doi.org/10.1016/j.chest.2020.12.057
Faria N, Costa MI, Gomes J, Sucena M. Reduction of servere exacerbations of COPD during COVID-19 pandemic in Portugal: A protective role of face masks? COPD 2021;18(2):226-230. https://doi.org/10.108 0/15412555.2021.1904387
Pedrozo-Pupo JC, Campo-Arias A. Depression, perceived stress related to COVID, post-traumatic stress, and insomnia among asthma and COPD patients during the COVID-19 pandemic. Chron Respir Dis 2020;17:1479973120962800. https://doi.org/10.1177/1479973120962800
Pleguezuelos E, del Carmen A, Moreno E, et al. The experience of COPD patients in lockdown due to the COVID-19 pandemic. Int J Chron Obstruct Pulmon Dis 2020;15:2621-2627. https://doi.org/10.2147/ COPD.S268421
Downloads
Published
Issue
Section
License
Copyright (c) 2022 L Farrant, R Harding, K Nkhoma, O Mzimkulu, J Hunter, L Gwyther
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
